Curexo Inc. (KOSDAQ:060280)
8,020.00
-150.00 (-1.84%)
Sep 11, 2026, 3:30 PM KST
Curexo Market Cap
Curexo has a market cap or net worth of 330.9 billion as of September 11, 2026. Its market cap has decreased by -8.17% in one year.
Market Cap
330.90B
Enterprise Value
305.69B
Revenue
77.74B
Ranking
n/a
PE Ratio
60.31
Stock Price
8,020.00
ChartMarket Cap Chart
Since November 3, 2004, Curexo's market cap has increased from 3.98B to 330.90B, an increase of 8,208.94%. That is a compound annual growth rate of 22.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 330.90B | -37.86% |
| Dec 30, 2025 | 532.53B | 100.62% |
| Dec 30, 2024 | 265.44B | -65.17% |
| Dec 28, 2023 | 762.19B | 191.52% |
| Dec 29, 2022 | 261.46B | 5.49% |
| Dec 30, 2021 | 247.86B | 18.34% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioNote | 480.85B |
| i-SENS | 477.64B |
| T&L Co., Ltd. | 448.79B |
| WON TECH | 428.80B |
| Samyang Biopharm | 370.31B |
| ToolGen | 304.49B |
| Value Added Technology | 265.74B |
| JETEMA, | 249.45B |